Tuberculosis Research and Treatment / 2014 / Article / Tab 1

Research Article

Profile, Outcomes, and Determinants of Unsuccessful Tuberculosis Treatment Outcomes among HIV-Infected Tuberculosis Patients in a Nigerian State

Table 1

Sociodemographic and clinical characteristics of 342 TB/HIV coinfected patients in Ebonyi State, Nigeria, stratified by tuberculosis treatment outcome.

CharacteristicsFrequency
(%)
Successful outcome
(%)
Unsuccessful outcome
(%)
value

Age (years)0.75
 ≤40255 (74.6)169 (66.3)86 (33.7)
 >4087 (25.4)56 (64.4)31 (35.6)
Gender0.50
 Female164 (48.0)105 (64.0)59 (36.0)
 Male178 (52.0)120 (67.4)58 (32.6)
Residence0.006
 Urban233 (68.1)83 (76.1)26 (23.9)
 Rural109 (31.9)142 (60.9)91 (39.1)
Facility<0.001
 Private251 (73.4)181 (72.1)70 (27.9)
 Public91 (26.6)44 (48.4)47 (51.6)
Type of TB0.42
 Pulmonary331 (96.8)219 (66.2)122 (33.8)
 Extrapulmonary11 (3.2)6 (54.5)5 (45.5)
Treatment category0.95
 New319 (93.3)210 (65.8)109 (34.2)
 Previously treated23 (6.7)15 (65.0)8 (35.0)
TB regimen received0.11
 Regimen 1196 (57.3)122 (62.2)74 (37.8)
 Regimen 2146 (42.7)103 (70.5)43 (29.5)
Received ART0.81
 Yes117 (34.2)78 (66.7)39 (33.3)
 No225 (65.8)147 (65.3)78 (34.7)
Received CPT0.97
 Yes189 (55.3)124 (65.6)65 (34.4)
 No153 (44.7)101 (66.0)52 (34.0)

Regimen 1: 2RHZE/6EH; regimen 2: 2RHZE/4RH (R: rifampicin, H: isoniazid, Z: pyrazinamide, and E: ethambutol); ART: antiretroviral therapy; TB: tuberculosis; HIV: human immunodeficiency virus; CPT: cotrimoxazole preventive therapy.